Skip to main content
SpringerLink
Log in

Sibutramine shown the door in the US, Australia, Canada and NZ

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Drug Safety Communication: FDA recommends against the continued use of Meridia (sibutramine). Internet Document: [2 pages], 8 Oct 2010. Available from: URL: http://www.fda.gov

  2. FDA.Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia. Media Release: 8 Oct 2010. Available from: URL: http://www.fda.gov

  3. Australian Government.Sibutramine (Reductil) - withdrawal in Australia. Internet Document: [1 page], 8 Oct 2010. Available from: URL: http://www.tga.gov.au

  4. Abbott.Abbott to Stop Marketing the Obesity Medicine Sibutramine in Canada. Media Release: 8 Oct 2010. Available from: URL: http://www.abbott.ca

  5. Health Canada.Abbott Laboratories Voluntarily Withdraws Weight-loss Drug Sibutramine (Meridia(Rm)) from the Canadian Market. Media Release: 8 Oct 2010. Available from: URL: http://www.hc-sc.gc.ca

  6. Medsafe.Withdrawal of Sibutramine (Reductil) in New Zealand. Media Release: 11 Oct 2010. Available from: URL: http://www.medsafe.govt.nz

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sibutramine shown the door in the US, Australia, Canada and NZ. React. Wkly. 1323, 4 (2010). https://doi.org/10.2165/00128415-201013230-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013230-00008

Keywords

Search

Navigation